Reportstack has announced a new market research report on the Global Cystic Fibrosis Market 2015-2019. CFTR modulator drugs are increasingly becoming the preferred choice of treatment for cystic fibrosis as these drugs target the molecular cause of cystic fibrosis. Since these drugs target the cause of the disease, they are gaining popularity among patients and the medical community as a preferred choice for the treatment of cystic fibrosis. The Global Cystic Fibrosis market is expected to grow at a CAGR of 32.5 percent during the forecast period of 2014-2019.
“Cystic fibrosis is a genetically inherited disease and there are various tests that can detect cystic fibrosis,”.
“Some of the most popular methods of diagnosis are antenatal testing, newborn screening, carrier testing, and other tests such as sweat tests and genetic tests.”
To define the market conditions in the next 3-4 years, the analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
Complete report with TOC available @ Global Cystic Fibrosis Market 2015-2019.